ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1897

Sexual Function and Health-related Quality of Life in Male Patients with Systemic Lupus Erythematosus, the Untold Story

Martín Valdez-López1, Jonathan Campos-Guzmán 1, Ana Barrera-Vargas 2, Samuel Govea-Peláez 1, Diana Gómez-Martín 1, Jorge Alcocer-Varela 1, Eduardo Aguirre-Aguilar 1, Diana Padilla-Ortíz 3 and Javier Merayo-Chalico 1, 1Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Distrito Federal, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico, 3Universidad De La Sabana, Bogotá, Cundinamarca, Colombia

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: quality of life, sexual and lymphopenia, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: 4M118: Reproductive Issues in Rheumatic Disorders (1896–1901)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Although SLE is uncommon in men, the disease is usually more severe and requires more aggressive immunosuppression in male patients. There are multiple studies evaluating the association between SLE and sexual function in female patients and its impact on their quality of life, but information regarding male patients is practically non-existent.

Methods: We performed a longitudinal study in a referral center in Mexico City (2018- 2019). We included men aged ≥16 years who fulfilled ACR criteria for SLE and who were sexually active in the previous six months. All subjects answered the International Index of Erectile Function-15 (IIEF-15), the SF-36 (which determines generic health-related quality of life) and the HAQ questionnaire in the basal and subsequent visits. Other clinical, serological and demographic variables were measured. Statistical analysis was performed with SPSS v21.

Results: We included 124 male SLE patients. Mean age was 36.8 (±11.8) years and most patients (88%) were taking immunosuppressive therapy. There was some degree of  sexual dysfunction in 58 (47.5%) of patients. Table 1 shows the different characteristics of patients with and without abnormalities in sexual function. Of note, men who presented some degree of sexual dysfunction had fewer years of schooling (p=0.010) and a higher HAQ score (p=0.011).

In the first visit, abnormalities in sexual function, as measured by IIEF-15, were associated with different spheres of the SF-36 score. The most relevant correlations between the different components of SF-36 and global IIEF-15 are shown in Fig 1. Other correlations were found between global IIEF-15 and the absolute neutrophil/lymphocyte ratio (r= -0.259, p=0.004), as well as the SLICC score (r= -0.262, p= 0.003). Correlations between these same variables remained significant in subsequent visits.

When asked, 84.3% of patients said they would like to have specialized care if they were diagnosed with sexual disfunction. Interestingly, only 22% of patients thought their disease could have repercussions on their sexual function. 

Conclusion: To our knowledge, this is the first study to show that sexual function in male SLE patients seems to be closely associated with the patients quality of life, particularly with its physical aspects. Higher prevalence in patients with low education may reflect the importance of the psychological components in the development of this complication. The association of lymphopenia with an impaired sexual function could be related to its role in endothelial dysfunction and atherosclerosis. These findings highlight the need  for rheumatologist to  promote and coordinate a multidisciplinary approach for male SLE patients with sexual dysfunction.


Table 1 SLE pdf

Table 1. Demographic, clinical and laboratory features -initial outpatient visit-; p value <0.05 are shown in bold.

Figure 1 All graphs show scatter plot comparing some of the different components of the SF-36 questionnaire, compared to the total IIEF-15. Pearson correlation coefficient and p value, are shown in each graphic. The most representative graphs were selected -with the upper half being from the first visit, and the lower half corresponding to the third visit-


Disclosure: M. Valdez-López, None; J. Campos-Guzmán, None; A. Barrera-Vargas, None; S. Govea-Peláez, None; D. Gómez-Martín, None; J. Alcocer-Varela, None; E. Aguirre-Aguilar, None; D. Padilla-Ortíz, None; J. Merayo-Chalico, None.

To cite this abstract in AMA style:

Valdez-López M, Campos-Guzmán J, Barrera-Vargas A, Govea-Peláez S, Gómez-Martín D, Alcocer-Varela J, Aguirre-Aguilar E, Padilla-Ortíz D, Merayo-Chalico J. Sexual Function and Health-related Quality of Life in Male Patients with Systemic Lupus Erythematosus, the Untold Story [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/sexual-function-and-health-related-quality-of-life-in-male-patients-with-systemic-lupus-erythematosus-the-untold-story/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sexual-function-and-health-related-quality-of-life-in-male-patients-with-systemic-lupus-erythematosus-the-untold-story/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology